StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note released on Friday. The firm issued a hold rating on the stock. Oncternal Therapeutics ...
NICE (Nasdaq: NICE) today announced that the Fire Department of New York (FDNY) has selected NICE Investigate, one of the solutions in NICE's Evidencentral platform, to digitally transform how it ...
News Medical on MSN19h
Microplastics in food packaging may increase heart disease riskMicroplastics pose a threat to heart health, causing harmful changes in vascular cells and increasing the risk of cardiovascular diseases like atherosclerosis.
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that ...
Intermittent fasting is becoming increasingly popular. But is it helpful for weight loss and other medical conditions?
Wrestling Inc. on MSN17h
Paul Heyman Explains Why WWE Deserves Emmy Award ConsiderationAppearing on the " Sports Media with Richard Deitsch " podcast, Heyman pointed out how wrestling today has many complex ...
Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...
Learn more about whether Protagonist Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on ...
Q3 2025 Results Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsCorey Davis - Investor Relations, ...
Happy Monday folks! Looking for the latest news from the genomics world and beyond? Week in Brief has you covered!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback